Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) FCF Margin (2016 - 2025)

Historic FCF Margin for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 8.83%.

  • Medifast's FCF Margin fell 27500.0% to 8.83% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.32%, marking a year-over-year decrease of 25000.0%. This contributed to the annual value of 0.32% for FY2025, which is 25000.0% down from last year.
  • As of Q4 2025, Medifast's FCF Margin stood at 8.83%, which was down 27500.0% from 12.02% recorded in Q3 2025.
  • Medifast's FCF Margin's 5-year high stood at 17.83% during Q1 2021, with a 5-year trough of 8.83% in Q4 2025.
  • In the last 5 years, Medifast's FCF Margin had a median value of 6.04% in 2024 and averaged 6.04%.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -226400bps in 2021, then surged by 177000bps in 2022.
  • Medifast's FCF Margin (Quarter) stood at 5.05% in 2021, then skyrocketed by 351bps to 12.65% in 2022, then plummeted by -60bps to 5.01% in 2023, then plummeted by -221bps to 6.08% in 2024, then crashed by -45bps to 8.83% in 2025.
  • Its FCF Margin stands at 8.83% for Q4 2025, versus 12.02% for Q3 2025 and 4.51% for Q2 2025.